Pharmx Technologies Ownership

PHX Stock   0.1  0  3.26%   
Pharmx Technologies owns a total of 598.51 Million outstanding shares. Pharmx Technologies has significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Since such a large part of the company is owned by insiders, it is advisable to analyze if each of these insiders have been buying or selling the stock in recent months. Please note that no matter how many assets the company maintains, if the real value of the company is less than the current market value, you may not be able to make money on it.
 
Shares in Circulation  
First Issued
1988-12-31
Previous Quarter
598.5 M
Current Value
598.5 M
Avarage Shares Outstanding
167.2 M
Quarterly Volatility
166 M
 
Oil Shock
 
Dot-com Bubble
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
  
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Pharmx Technologies. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

Pharmx Stock Ownership Analysis

About 56.0% of the company outstanding shares are owned by corporate insiders. The book value of Pharmx Technologies was at this time reported as 0.03. The company last dividend was issued on the 28th of November 2023. Pharmx Technologies had 1:10 split on the 31st of October 2005. To find out more about Pharmx Technologies contact the company at 61 1300 724 579 or learn more at https://pharmx.com.au.

Pharmx Technologies Outstanding Bonds

Pharmx Technologies issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Pharmx Technologies uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Pharmx bonds can be classified according to their maturity, which is the date when Pharmx Technologies has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for Pharmx Stock Analysis

When running Pharmx Technologies' price analysis, check to measure Pharmx Technologies' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Pharmx Technologies is operating at the current time. Most of Pharmx Technologies' value examination focuses on studying past and present price action to predict the probability of Pharmx Technologies' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Pharmx Technologies' price. Additionally, you may evaluate how the addition of Pharmx Technologies to your portfolios can decrease your overall portfolio volatility.